Dr. Macey Levan — NYU transplant researcher, former OPTN Board Executive Committee member, living kidney donor, and national transplantation leader — joins C&C for a special live episode at the 51st Annual ASHI Meeting in Orlando, FL, to talk all things transplant “modernization” and the state of xenotransplantation.🔔 Subscribe to our channel for more expert discussions, insights into innovation, and practical tips on patents, diagnostics, and technology commercialization. Stay updated with the latest trends in science and intellectual property!Tip: Click the CC button, then Settings → Subtitles → Auto-translate to watch with captions in Spanish or other languages.Hashtags:#Innovation #TechnologyTransfer #Commercialization #Patents #DiagnosticAssays #IntellectualProperty #IPProtection #ScientificInnovation #ResearchToMarket #TechInnovation #StartupScience #BiotechInnovation #TranslationalResearch #ScienceEntrepreneurship #LabToMarket
Discover how collaboration can strengthen our field! Join special guest Dr. Debby Basu as she shares the latest American Society for Clinical Pathology (ASCP) projects and initiatives designed to support and empower the clinical laboratory workforce — including opportunities that could directly benefit you.
Technology transfer and commercialization expert Dr. Kelly Parsons discusses the current state of patents and diagnostic assays. Learn essential strategies for protecting intellectual property, navigating patent processes, and translating scientific discoveries into real-world applications. Whether you’re a researcher, entrepreneur, or innovator, this discussion offers valuable insights into bridging the gap between the lab and the market.
Dr. Chris Wiebe shares his expertise in use of HLA eplet mismatch load in estimating immunologic risk in transplantation. We cover considerations of de novo HLA-DSA formation, donor selection, impacts on post-transplant monitoring protocols, as well as immunosuppression.
Whether you work in an HLA lab or rely on one for clinical services or care, you won’t want to miss this episode of Coffee & Compatibility! James Robinson, founder of the bioinformation IPD-IMGT/HLA Database, joins us to share how this essential tool evolved into a global resource with over 74,000 submissions, 42,000+ alleles, and nearly 20 new entries every day!
Dorrie Dils, President of the Association of Organ Procurement Organizations, joins the podcast to discuss major changes in federal oversight of OPOs and what they mean for the transplant community.CBS News Video Story: https://www.cbsnews.com/video/a-final...CBS News Print Story: https://www.cbsnews.com/organdonors/New York Times Article: https://www.nytimes.com/interactive/2...
Today's episode features Dr. Stanley Jordan, as he discusses recent advances in desensitization therapies and exciting new approaches coming soon.
🎉 Get 10% Off at the ASHI Store! BUT FIRST SUBSCRIBE 🎉Use code YOTL2025 at checkout to enjoy 10% off your purchase.👉 Shop Now at the ASHI Store [https://theashistore.square.site/]
Dr. Geoffrey Funk, OPO CEO, joins Coffee & Compatibility to explain what NRP is, how it has impacted solid organ transplant allocation, and why some see it as controversial.🎉 Get 10% Off at the ASHI Store! BUT FIRST SUBSCRIBE 🎉Use code YOTL2025 at checkout to enjoy 10% off your purchase.👉 Shop Now at the ASHI Store [https://theashistore.square.site/]
Valen Keefer, a two-time transplant recipient and leading patient advocate, shares her story and insights with the Coffee & Compatibility crew.
Madam President and all-around Immunogenetics boss, Dr. Cathi Murphey joins the podcast to discuss recent CMS updates, guidance, and clarifications on HLA testing and personnel.
What will the next 50 years hold for ASHI? Katie Mellon joins the podcast to discuss how ASHI can attract the next generation of technologists and reflects on her experience at her first ASHI Annual Meeting!
🎉 Get 10% Off at the ASHI Store! 🎉
Use code WITTYBANTER at checkout to enjoy 10% off your purchase.
👉 Shop Now at the ASHI Store
Become an ASHI member!
https://www.ashi-hla.org/page/membership
CMS Final Rule - pg 256
https://www.cms.gov/files/document/qso-25-10-clia.pdf
Coffee & Compatibility goes live from the 50th Annual ASHI Meeting! Tune in to hear Dr. Annette Jackson, Rebecca Upchurch, and Dr. Anne Halpin share their insights on the changing regulatory landscape and what it means for your lab. Plus, questions from our live audience!
HLA Director and Transfusion Medicine Specialist, Dr. Ryan Pena, joins Coffee & Compatibility to discuss how HLA laboratories can support transfusion medicine specialists. From HLA typing to anti-HLA antibody analysis in this niche service, Dr. Pena breaks it all down.
Dr. Gerald Morris, the current Chair of the OPTN Histocompatibility Committee, joins Coffee & Compatibility to discuss upcoming changes in HLA testing and nomenclature, and their potential impacts on organ allocation in the United States.
Dr. Zahra Kashi and Russell Martin share how Kashi Laboratory developed their HLA molecular testing menu and how they expanded into non-HLA molecular diagnostics. Tune in to find out what non-HLA molecular diagnostic testing may be the future for HLA laboratories.
Dr. Medhat Askar joins the podcast to discuss the utility and validation of donor-derived cell-free DNA (dd-cfDNA) testing for solid-organ recipients. Dr. Askar also discusses the regulatory status of dd-cfDNA in the United States.
Dr. Christina Jorge shares what has made Portugal’s organ allocation system one of the best in the world, as well as the challenges it faces and the innovations it has planned.
Organ allocation expert Larry Suplee joins Coffee & Compatibility to discuss the strengths of the U.S. organ allocation system and explore future improvements.
Trailblazer Donna Phelan shares her journey in HLA including moments of special connection with ASHI’s mission, groundbreaking advances in technology, and paving the way for technologist leadership in ASHI!
Kicking off a celebration of ASHI’s 50th anniversary, the podcast welcomes Dr. Carolyn Hurley for a conversation about the history and future of ASHI.